Novoprotein Scientific Inc. (SHA:688137)
43.10
+2.05 (4.99%)
At close: Mar 10, 2026
Novoprotein Scientific Revenue
In the year 2025, Novoprotein Scientific had annual revenue of 151.51M CNY with 18.78% growth. Novoprotein Scientific had revenue of 39.66M in the quarter ending December 31, 2025, with 11.78% growth.
Revenue
151.51M
Revenue Growth
+18.78%
P/S Ratio
18.90
Revenue / Employee
267.69K
Employees
556
Market Cap
2.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 151.51M | 23.96M | 18.78% |
| Dec 31, 2024 | 127.56M | -25.64M | -16.73% |
| Dec 31, 2023 | 153.19M | -111.36M | -42.09% |
| Dec 31, 2022 | 264.55M | -77.34M | -22.62% |
| Dec 31, 2021 | 341.90M | 162.05M | 90.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.07B |
| Shandong Sito Bio-technology | 954.76M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Guangdong VTR Bio-Tech | 830.87M |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |
| Cabio Biotech (Wuhan) | 574.88M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Jiangsu Sihuan Bioengineering | 341.90M |